Schröder, J., Fauth Silvestri, S., Bubeck, B., Karr, M., Demisch, S., Scherrer, S., . . . Sauer, H. (1998). D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: A follow-up study with 123I-Iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment. Biological psychiatry, 43(9), . https://doi.org/10.1016/S0006-3223(97)00442-3
Chicago Style (17th ed.) CitationSchröder, Johannes, Simone Fauth Silvestri, Bernd Bubeck, Markus Karr, Sibylle Demisch, Sabine Scherrer, Franz Josef Geider, and Heinrich Sauer. "D2 Dopamine Receptor Up-regulation, Treatment Response, Neurological Soft Signs, and Extrapyramidal Side Effects in Schizophrenia: A Follow-up Study with 123I-Iodobenzamide Single Photon Emission Computed Tomography in the Drug-naive State and After Neuroleptic Treatment." Biological Psychiatry 43, no. 9 (1998). https://doi.org/10.1016/S0006-3223(97)00442-3.
MLA (9th ed.) CitationSchröder, Johannes, et al. "D2 Dopamine Receptor Up-regulation, Treatment Response, Neurological Soft Signs, and Extrapyramidal Side Effects in Schizophrenia: A Follow-up Study with 123I-Iodobenzamide Single Photon Emission Computed Tomography in the Drug-naive State and After Neuroleptic Treatment." Biological Psychiatry, vol. 43, no. 9, 1998, https://doi.org/10.1016/S0006-3223(97)00442-3.